Formulation and Evaluation of Transdermal Patch of Repaglinide
Repaglinide has the half life of 1 hour, and bioavailability in the body is 56% due to first-pass metabolism. The total daily dose of Repaglinide is 16 mg (e.g., 4 mg four times daily depending on meal patterns); hence, it required frequent dosing. Transdermal patch of Repaglinide was prepared to su...
| Main Authors: | , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
International Scholarly Research Network
2011
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3263722/ |